Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2212-2224
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2212
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2212
Table 2 Sub-group analysis of the association between T cell immunoglobulin and mucin-domain containing-3 and the clinicopathological parameters
| Subgroups | OR (95%CI) | P value | Studies, n | Patients, n |
| Sex: Female vs male | 0.92 (0.75-1.14) | 0.388 | 7 | 1866 |
| Age: Elderly vs non-elderly | 1.07 (0.79-1.44) | 0.061 | 6 | 1771 |
| Tumor location: Top and middle vs bottom | 1.07 (0.85-1.35) | 0.605 | 4 | 1311 |
| Tumor size: 4 vs < 4 | 0.77 (0.53-1.12) | 0.202 | 4 | 1192 |
| T stage: T1-2 vs T3-4 | 1.39 (1.06-1.83) | 0.6 | 3 | 865 |
| N stage: N0-1 vs N2-3 | 1.5 (1.11-2.01) | 0.803 | 3 | 865 |
| TNM Stage: III/IV vs I/II | 1.21 (0.63-2.33) | < 0.001 | 7 | 1866 |
| Grade: G1 vs G2 + G3 | 0.7 (0.40-1.22) | 0.427 | 3 | 323 |
- Citation: Yan JJ, Liu BB, Yang Y, Liu MR, Wang H, Deng ZQ, Zhang ZW. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis. World J Gastrointest Oncol 2023; 15(12): 2212-2224
- URL: https://www.wjgnet.com/1948-5204/full/v15/i12/2212.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i12.2212